Champions Oncology Inc (NASDAQ:CSBR) Beats Revenue Estimates and Returns to Profitability in Q2 Champions Oncology beats Q2 revenue estimates, returns to profit with record service revenue and expanding margins.
Champions Oncology Inc (NASDAQ:CSBR) Reports Q1 Fiscal 2026 Earnings with Record Revenue but Wider-Than-Expected Loss Champions Oncology posts record Q1 FY26 revenue of $14.0M but reports a wider-than-expected loss due to increased strategic investments in its data platform.
4 Biotech Stocks That Are Showing Weakness: Momentum Scores Fading Over The Past Week Several biotech stocks have seen their strength fade over the past week, with their Momentum scores in Benzinga's Edge Stock Rankings witnessing a significant decline.
CSBR Stock Earnings: Champions Oncology Beats EPS, Beats Revenue for Q4 2024 CSBR stock results show that Champions Oncology beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024.
Insiders Buying Solid Biosciences And 2 Other Stocks Although U.S. stocks closed mixed on Friday, there were a few notable insider trades.
Insiders Buying Tilly's And 2 Other Stocks Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades.
Earnings Scheduled For March 12, 2024 Companies Reporting Before The Bell • Aurora Mobile (
NASDAQ:JG ) is likely to report earnings for its fourth quarter.
Why Is RiskOn International (ROI) Stock Up 28% Today? RiskOn International stock is rising higher on Wednesday as investors react to insider buying of ROI shares by Milton C. Ault III.
CSBR Stock Earnings: Champions Oncology Beats EPS, Misses Revenue for Q2 2024 CSBR stock results show that Champions Oncology beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
